Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma
NCT01241708
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
148
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Auto Stem Cell Transplant
Interventions
DRUG:
Bortezomib
Sponsor
Hackensack Meridian Health